Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) has shared an announcement.
China Resources Pharmaceutical Group Ltd. announced the successful issuance of the first tranche of its 2025 corporate bonds in China, amounting to RMB1.1 billion with a 1.82% annual coupon rate. The proceeds will be used for various operational and developmental purposes, including debt repayment and investment in scientific and technological innovations, potentially enhancing the company’s operational capabilities and market position.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and healthcare services in China.
Average Trading Volume: 17,056,642
Technical Sentiment Signal: Sell
Current Market Cap: HK$29.84B
For a thorough assessment of 3320 stock, go to TipRanks’ Stock Analysis page.